Shang Lin to Risk Assessment
This is a "connection" page, showing publications Shang Lin has written about Risk Assessment.
Connection Strength
0.093
-
Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? Clin Gastroenterol Hepatol. 2008 Feb; 6(2):159-64.
Score: 0.046
-
Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Am J Gastroenterol. 2009 Nov; 104(11):2684-92.
Score: 0.013
-
Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Gastrointest Endosc. 2009 Sep; 70(3):417-21.
Score: 0.013
-
Predicting the risk of patients with biopsy Gleason score 6 to harbor a higher grade cancer. J Urol. 2007 Nov; 178(5):1925-8.
Score: 0.011
-
Effect of prostate weight on operative and postoperative outcomes of robotic-assisted laparoscopic prostatectomy. Urology. 2007 Feb; 69(2):300-5.
Score: 0.011